Opinion

Video

Review of the COMMANDS Trial

The experts examine the COMMANDS trial, which assessed luspatercept in lower-risk myelodysplastic syndrome patients, detailing the trial's design, participant groups, and key outcome measures.

Related Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Video 8 - 2 KOLs are featured in, "Emerging Trials in the Management of HR+/HER2- mBC"
Video 7 - 2 KOLs are featured in, "Adverse Event Data and Management for Optimal Quality of Life in HR+/HER2- mBC"
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
2 KOLs are featured in this series
2 KOLs are featured in this series
5 KOLs are featured in this peer exchange